Integer Holdings' growth momentum has faded, with revenue declining 1.8% year-over-year in 2026Q2, and gross margin contracting 320 basis points from 27.5% in 2024Q2 to 24.3% in 2026Q2, indicating eroding pricing power and potential demand weakness. While cash...
Price trend, volume and key moving averages
Trailing total returns as of 10/3/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Check whether operating performance supports the current valuation.
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q3 2026Latest Aug 3, 2026 | $1.60+15.9% vs $1.38 | $464M+2.9% vs $451M |
Q2 2026 Apr 30, 2026 | $1.20-0.8% vs $1.21 | $440M+3.1% vs $426M |
Q1 2026 Feb 19, 2026 | $1.76+3.5% vs $1.70 | $472M+2.0% vs $463M |
Q4 2025 Oct 23, 2025 | $1.79+6.5% vs $1.68 | $468M+1.1% vs $463M |
Investors interested in Medical - Instruments stocks are likely familiar with Globus Medical (GMED) and Integer (ITGR). But which of these two stocks offers value investors a better bang for their buck right now?
PLANO, Texas, Sept. 30, 2026 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR) (“Integer” or the “Company”), a leading global medical device contract development and manufacturing organization (CDMO), today announced that it has received early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (“HSR”), in connection with the previously announced acquisition of Integer by an affiliate of investment funds managed by KKR (the “Merger”).
Shares of Integer Holdings Corporation (NYSE: ITGR - Get Free Report) saw unusually-strong trading volume on Monday. Approximately 894,353 shares were traded during mid-day trading, an increase of 16% from the previous session's volume of 769,018 shares. The stock last traded at $126.2950 and had previously closed at $126.34. Wall Street Analyst Weigh In A number
ITGR's $127-a-share KKR deal offers defined cash value, while core franchises face slow new-product adoption.
Benchmark ITGR against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for Integer Holdings Corporation (ITGR)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $126.45 | $4.29B | 43.75 | 7.57% | 5.57% | 6.11% | — | |
| $14.94 | $1.73B | -12.25 | 8.28% | -21.25% | -44% | — | |
| $75.07 | $4.12B | -16.87 | 10.74% | 12.82% | 15.41% | — | |
| $19.10 | $255.61M | -25.13 | -5.91% | -3.14% | -2.7% | — | |
| $10.27 | $101.36M | -3.90 | 15.21% | -13.99% | -20.59% | — | |
| $55.14 | $2.8B | -229.75 | 14.88% | 1.85% | 2.14% | — |
Integer Holdings Corporation (ITGR) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Verify the primary filings, follow material updates, and answer the remaining questions.
Integer Holdings Corporation (ITGR) SEC filings — annual & quarterly reports (10-K, 10-Q)
Aug 4, 2026·SEC
Aug 3, 2026·SEC
Aug 3, 2026·SEC
Get notified when ITGR posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Integer Holdings Corporation (ITGR) stock FAQ — growth, dividends, profitability & financials explained
Integer Holdings Corporation (ITGR) reported $1.84B in revenue for fiscal year 2025. This represents a 2224% increase from $79.2M in 1999.
Integer Holdings Corporation (ITGR) grew revenue by 7.6% over the past year. This is steady growth.
Yes, Integer Holdings Corporation (ITGR) is profitable, generating $128.4M in net income for fiscal year 2025 (5.6% net margin).
Integer Holdings Corporation (ITGR) has a return on equity (ROE) of 6.1%. This is below average, suggesting room for improvement.
Integer Holdings Corporation (ITGR) generated $112.0M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.
